Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Here’s Why

Anbio Biotechnology (NASDAQ:NNNN) shares gapped down prior to trading on Friday . The stock had previously closed at $21.51, but opened at $20.64. Anbio Biotechnology shares last traded at $21.5750, with a volume of 2,254 shares changing hands.

Analysts Set New Price Targets

Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, February 9th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Anbio Biotechnology Trading Up 9.4%

Anbio Biotechnology (NASDAQ:NNNN) last issued its quarterly earnings results on Tuesday, December 30th. The company reported $0.04 earnings per share for the quarter. The business had revenue of $2.29 million during the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.